Improved renal function in neurofibromatosis type 1 patients.

Area of Science:

• Nephrology
• Genetics
• Internal Medicine

Background:

• Neurofibromatosis type 1 (NF1), also known as von Recklinghausen disease, is an autosomal dominant disorder.
• NF1 is associated with diverse symptoms, including café-au-lait spots and neurofibromas, and can affect renal function via renal artery vasculopathy.
• Previous studies indicated lower peripheral blood creatinine in male NF1 patients, but comprehensive renal function assessment in NF1 remains limited.

Purpose of the Study:

• To comprehensively assess and compare renal function in patients with Neurofibromatosis type 1 (NF1) against a control group.
• To investigate differences in key renal function markers, including creatinine, blood urea nitrogen, and estimated glomerular filtration rate (eGFR).

Main Methods:

• A cohort study involving 149 NF1 patients and 159 controls, matched for age and BMI.
• Analysis of peripheral blood markers: creatinine, blood urea nitrogen (BUN), and hemoglobin A1c (HbA1c).
• Urinalysis for protein, occult blood, and sugar; calculation of estimated glomerular filtration rate (eGFR).

Main Results:

• NF1 patients exhibited significantly lower mean creatinine levels compared to controls.
• The mean eGFR was significantly higher in NF1 patients, suggesting enhanced glomerular filtration.
• Blood urea nitrogen levels did not differ significantly, but the BUN-to-creatinine ratio was higher in NF1 patients.
• NF1 patients showed significantly lower mean HbA1c levels.

Conclusions:

• NF1 patients may possess improved renal function, characterized by higher eGFR and lower creatinine.
• The observed differences in renal function markers warrant further investigation into their clinical significance and underlying mechanisms.
• These findings could impact the clinical management and monitoring of kidney health in NF1 patients.